Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPK alpha 1/ULK1/FUNDC1/mitophagy pathway

Cai, C; Guo, ZZ; Chang, X; Li, ZY; Wu, F; He, J; Cao, TT; Wang, KR; Shi, NX; Zhou, H; Toan, S; Muid, D; Tan, Y

Tan, Y (通讯作者),Southern Med Univ, Dept Crit Care Med, Nanfang Hosp, Sch Clin Med 1, Guangzhou 510515, Peoples R China.

REDOX BIOLOGY, 2022; 52 ():

Abstract

Mitophagy preserves microvascular structure and function during myocardial ischemia/reperfusion (I/R) injury. Empagliflozin, an anti-diabetes drug, ma......

Full Text Link